Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation

BB AggarwalA BhardwjRS AggarwalNP SeeramS ShishodiaY TakadaRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2427832840200415517885

JK KunduKS ChunSO KimYJ SurhResveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targetsBiofactors2l3339200410.1002/biof.55221010815630167

MH AzizR KumarN AhmadCancer chemoprevention by resveratrol in vitro and in vivo studies and the underlying mechanisms (review)Int J Oncol231728200312792772

H JiangU ZhangJ KuoResveratrol-induced apoptotic death in human U251 glioma cellsMol Cancer Ther4554561200510.1158/1535-7163.MCT-04-005615827328

TT WangNW SchoeneEK KimYS KimPleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaPMol CarcinogApr112012(Epub ahead of print)10.1002/mc.21906

ME JuanI AlfarasJM PlanasColorectal cancer chemoprevention by trans-resveratrolPharmacol Res65584591201210.1016/j.phrs.2012.03.01022465196

P LiuX WangC HuT HuInhibition of proliferation and induction of apoptosis by trimethoxyl stilbene (TMS) in a lung cancer cell lineAsian Pac J Cancer Prev1222632269201122296367

JH ZhouHY ChengZQ YuResveratrol induces apoptosis in pancreatic cancer cellsChin Med J (Engl)12416951699201121740780

HB YuHF ZhangX ZhangResveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanismHepatogastroenterology5712411246201021410066

Y LiCM BäckesjöLA HaldosénU LindgrenResveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cellsEur J Pharmacol6091318200910.1016/j.ejphar.2009.03.00419285066

HF DvorakLF BrownM DetmarAM DvorakVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisAm J Pathol1461029103919957538264

G RanieriR PatrunoE RuggieriS MontemurroP ValerioD RibattiVascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinicCurr Med Chem1318451857200610.2174/09298670677758505916842197

LC BakerJK BoultS Walker-SamuelThe HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular functionBr J Cancer10616381647201210.1038/bjc.2012.13122498643

P RieskeJK BartkowiakAM SzadowskaB OlborskiB Harezga-BalM Debiec-RychterA comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomasJ Exp Clin Cancer Res18403416199910606188

AL KimY ZhuH ZhuResveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and Ap-1 signalling pathwaysExp Dermatol15538546200610.1111/j.1600-0625.2006.00445.x16761963

N KuwajerwalaE CifuentesS GautamResveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesisCancer Res6224882492200211980638

S VyasY AsmeremDD De LeónResveratrol regulates insulin-like growth factor-II in breast cancer cellsEndocrinology14642244233200510.1210/en.2004-134416037384

L GolkarXZ DingMB UjikiResveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1J Surg Res138163169200710.1016/j.jss.2006.05.037

J Gora-TyborJZ BlonskiT RobakCirculating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemiaEur Cytokine Netw164146200515809205

DJ HicklinLM EllisRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol2310111027200510.1200/JCO.2005.06.08115585754